F-group (family)
2003.1.4.5 SIR2
Ligands and drugs
773
Member domains
390
with ligand contacts (≤ 4 Å)
50.5% of members
342
with DrugDomain annotations
44.2% of members
270
with a DrugBank compound
34.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.4.5 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02059 | AR6 | Adenosine-5-Diphosphoribose | 93 |
| DB14128 | NAD | Nadide | 23 |
| DB02498 | CNA | Carba-nicotinamide-adenine-dinucleotide | 20 |
| DB02701 | NCA | Nicotinamide | 19 |
| DB17057 | SR7 | SRT-1720 | 12 |
| DB03478 | OAD | 2'-O-Acetyl Adenosine-5-Diphosphoribose | 9 |
| DB02709 | STL | Resveratrol | 7 |
| DB00123 | LYS | Lysine | 6 |
| DB00149 | LEU | Leucine | 6 |
| DB04381 | CRD | Crotonaldehyde | 6 |
| DB08168 | MCM | Coumarin 120 | 6 |
| DB04216 | QUE | Quercetin | 4 |
| DB01118 | BBI | Amiodarone | 3 |
| DB03345 | BME | Mercaptoethanol | 3 |
| DB15493 | — | — | 3 |
| DB01015 | 08D | Sulfamethoxazole | 2 |
| DB02095 | ISN | Isatin | 2 |
| DB03088 | PCA | Pidolic acid | 2 |
| DB03309 | NHE | N-cyclohexyltaurine | 2 |
| DB03407 | 4NC | 4-Nitrocatechol | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AR6 | [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE | 101 |
| ZNmetal | ZINC ION | 67 |
| CL | CHLORIDE ION | 33 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 31 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 25 |
| CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 23 |
| NCA | NICOTINAMIDE | 19 |
| NAmetal | SODIUM ION | 18 |
| UNX | UNKNOWN ATOM OR ION | 15 |
| SR7 | N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide | 12 |
| OCZ | (1S)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1- carboxamide | 10 |
| 8L9 | 5-[[3,5-bis(chloranyl)phenyl]sulfonylamino]-2-[(5-bromanyl-4-fluoranyl-2-methyl-phenyl)sulfamoyl]benzoic acid | 9 |
| OAD | 2'-O-ACETYL ADENOSINE-5-DIPHOSPHORIBOSE | 9 |
| KMQ | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{R},4~{R},5~{S})-4-[(~{E})-but-2-enoxy]-3,5-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | 8 |
| STL | RESVERATROL | 8 |
| A2N | [(2R,3S,4R,5R)-4-(acetylamino)-3,5-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 6 |
| BV8 | 3-[[(~{Z})-~{C}-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]sulfanyl-~{N}-[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino)hexyl]carbonimidoyl]amino]propanoic acid | 6 |
| CRD | (2E)-BUT-2-ENAL | 6 |
| LEU | LEUCINE | 6 |
| MYR | MYRISTIC ACID | 5 |